Patents Assigned to PANTARHIN PHARMA LLC
  • Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
    Patent number: 11000575
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: May 11, 2021
    Assignee: Pantarhin Pharma LLC
    Inventors: Dieter Cullmann, Gunther Burgard
  • Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
    Patent number: 10086051
    Abstract: The present invention relates to the use of hyaluronidase for the prevention and/or treatment of arterial hypertension or cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating arterial hypertension or cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: October 2, 2018
    Assignee: PANTARHIN PHARMA LLC
    Inventors: Dieter Cullmann, Gunther Burgard